Advisory Board

Meet the folks who lend their experience to our efforts

You are here: Home / Company / Advisory Board

Edico Genome’s Advisory Board is comprised of leading experts in the biotech and genomics industry.

Dr. Eric Topol M.D.

Scripps Translational Science Institute

Voted as the #1 Most Influential Physician Executive in the United States in 2012 in a national poll conducted by Modern Healthcare, Dr. Topol works on genomic and wireless digital innovative technologies to reshape the future of medicine. He is a practicing cardiologist at Scripps in La Jolla, California and widely credited for leading the Cleveland Clinic to become the #1 center for heart care. While there he also started a new medical school, led many worldwide clinical trials to advance care for patients with heart disease, and spearheaded the discovery of multiple genes that increase susceptibility for heart attacks. Since 2006, in La Jolla, he leads the flagship NIH supported Scripps Translational Science Institute and is a co-Founder of the West Wireless Health Institute. He also serves as Professor of Genomics at The Scripps Research Institute and Chief Academic Officer of Scripps Health.

Charles Cantor Ph.D.

Human Genome Project and Sequenom

Dr. Charles Cantor is one of the pioneers of the Human Genome Project, Chairman of Sequenom, Inc.’s Scientific Advisory Board, and was appointed Chief Scientific Officer in June 1998. Dr. Cantor was previously the chair and professor of the department of biomedical engineering and biophysics, and director of the Center for Advanced Biotechnology at Boston University. Prior to this Dr. Cantor was chairman at Columbia University College of Physicians & Surgeons, and Professor of Molecular Biology, University of California, Berkeley. He was also director of the Human Genome Center Project of the Department of Energy at Lawrence Berkeley Laboratory. Dr. Cantor is a consultant to more than 16 biotech firms, has published over 400 peer reviewed articles, authored and co-authored over 50 US and international patents, and co-authored a three-volume textbook on biophysical chemistry. He is also an author of the first genomics textbook, Genomics: The Science and Technology of the Human Genome Project.

Nils Homer Ph.D.

Broad Institute

Nils Homer is a genomics informatics leader and bioinformatics expert. Dr. Homer is currently managing genomics platform software engineering at the Broad Institute. Previously he has worked at Claritas Genomics and led a group of software developers, bioinformaticians, molecular biologists, statistical geneticists and IT engineers to develop enterprise solutions for the application of genomic infrastructure and scientific projects at Life Technologies.

Patrick Merel Ph.D.

Portable Genomics

Patrick is a Molecular Diagnostics expert. He was formerly the group leader at Biomedical Innovation Platform at the University Hospital of Bordeaux. He is an Inventor and entrepreneur and is currently the Founder and CEO of Portable Genomics based in San Diego, CA.

Ali Tinazli, Ph.D.


After receiving his Ph.D. in Germany and being published in high impact journals such as EMBO, Nature Cell Biology, Nature Nanotechnology, Dr. Tinazli was in corporate development at Applied Biosystems (now: Thermo Fisher) and covered the European landscape in biotech and in-vitro diagnostics innovation. Ali Tinazli co-started in 2008 Sony DADC BioSciences, a new biomedical business, which became recently an independent company within SONY Corporation. Dr. Ali Tinazli joined HP Inc. in 2015 and is leading the strategy for healthcare and life sciences.